Michael A Fifer

7PUBLICATIONS
51CO-AUTHORS
Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 25, 2026
International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

|Oct 09, 2025
Endothelial Cell-Related Proteins in Plasma Predict Major Adverse Cardiovascular Events and Worsening Heart Failure in Patients With Hypertrophic Cardiomyopathy.

Shogo Tamura, Keitaro Akita, Michael A Fifer

|Jan 20, 2025
Plasma SVEP1 Levels Predict Cardiovascular Events in Hypertrophic Cardiomyopathy Beyond Conventional Clinical Risk Models Including NT-proBNP.

Itsuki Osawa, Keitaro Akita, Kohei Hasegawa

|Nov 11, 2024
Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy From Other Cardiomyopathies With Left Ventricular Hypertrophy.

Keitaro Akita, Mathew S Maurer, Albree Tower-Rader

|Oct 23, 2024
Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using plasma proteomics profiling.

Heidi S Lumish, Nina Harano, Lusha W Liang

|Jun 12, 2023
Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways.

Lusha W Liang, Kohei Hasegawa, Mathew S Maurer

Pageof 2

Frequent Collaborators

6 joint publications

Yuichi J Shimada

4 joint publications

Kohei Hasegawa

4 joint publications

Mathew S Maurer

4 joint publications

Albree Tower-Rader